Search results for "death"

showing 10 items of 1744 documents

Night Work and Mortality: Prospective Study Among Finnish Employees Over the Time Span 1984 to 2008

2012

There is considerable evidence showing that night work is associated with increased morbidity, but only a few studies have focused on its relation to mortality. This study investigates the relationship between the type of working-time arrangement (weekly night work/daytime work) and total and cause-specific mortality among men and women. The data consist of a representative working conditions survey of Finnish employees conducted in 1984 (2286 men/2216 women), which has been combined with register-based follow-up data from Statistics Finland covering the years 1985-2008. In the 1984 survey, the employees were asked if they worked during the night (23:00-06:00 h) and if so, how often. In thi…

AdultMaleGerontologyWorkPhysiologyOccupational safety and healthSex FactorsRisk FactorsCause of DeathNeoplasmsSurveys and QuestionnairesWork Schedule TolerancePhysiology (medical)Risk of mortalityHumansMedicineProspective StudiesOccupationsProspective cohort studyNight workFinlandOccupational HealthProportional Hazards ModelsCause of deathProportional hazards modelbusiness.industryData Collectionta5142Middle AgedConfidence intervalRelative riskFemalebusinessDemographyChronobiology International
researchProduct

Measuring the burden of disease and injury in Spain using disability-adjusted life years: An updated and policy-oriented overview

2011

Summary Objective To provide a comprehensive and detailed overview of the burden of disease in Spain for 2008. Implications for public health policies are discussed. Study design Cross-sectional population-based study. Methods Disability-adjusted life years (DALYs) were calculated at country level using the methodology developed in the Global Burden of Disease study. DALYs were divided into years of life lost and years of life lived with disability. Results were obtained using Spanish mortality data for 2008 and morbidity data estimated previously by the World Health Organization for Euro-A. Results In 2008, DALYs lost due to all diseases and injuries were estimated at 5.1 million. Non-comm…

AdultMaleGerontologymedicine.medical_specialtyAdolescentCross-sectional studyPopulationPopulation healthYoung AdultCost of IllnessCause of DeathEnvironmental healthHumansMedicineDisabled PersonsChildeducationHealth policyDepression (differential diagnoses)Agededucation.field_of_studybusiness.industryHealth PolicyPublic healthPublic Health Environmental and Occupational HealthInfantGeneral MedicineMiddle AgedQuality-adjusted life yearCross-Sectional StudiesYears of potential life lostSpainChild PreschoolWounds and InjuriesFemaleQuality-Adjusted Life YearsbusinessPublic Health
researchProduct

Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: The LipoLab Study

2020

Background and aim Atherosclerosis is the underlying process in cardiovascular disease (CVD), the first cause of death in developed countries. We aimed to identify people with no known CVD and normal values of LDL-C and HDL-C, but with alterations in the number and size of lipoprotein particles (as measured by nuclear magnetic resonance [NMR]) and to analyse their sociodemographic, clinical and biochemical characteristics. Methods Cross-sectional study in occupational risks prevention centre in Castellon (Spain) in 2017 and 2018, in consecutively recruited adults (18-65 years) with no known CVD. Sociodemographic, clinical and biochemical variables were collected. Lipid profiles were analyse…

AdultMaleMagnetic Resonance SpectroscopyAdolescentLipoproteinsNormal valuesfamily practice030204 cardiovascular system & hematologyLogistic regressionLipoprotein particleYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNuclear magnetic resonancecardiovascular diseaseHumansWorking populationMedicine030212 general & internal medicineAgedCause of deathLDL particlesbusiness.industryCholesterolCholesterol HDLGeneral MedicineMiddle AgedNMRCross-Sectional StudiesBlood pressurechemistrySpainHDL particlesFemalelipids (amino acids peptides and proteins)businessLipoproteinInternational Journal of Clinical Practice
researchProduct

Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal c…

2003

The combination of irinotecan (CPT-11), bolus 5-fluorouracil (5-FU) and folinic acid (FA) (Saltz regimen) has recently been questioned as first-line chemotherapy for metastatic colorectal cancer after high early death rates due to gastrointestinal and thromboembolic events were reported in two US trials. Therefore, we carefully evaluated the safety and efficacy of this regimen, with high value placed on the management of delayed diarrhea. Forty-six patients with metastatic colorectal cancer received this first-line treatment in nine German outpatient clinics. Dose reductions were mandatory from the first cycle in case of toxicity grade2. Chemotherapy was administered only to diarrhea-free p…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentLeucovorinEarly deathIrinotecanFolinic acidBolus (medicine)Internal medicineAntineoplastic Combined Chemotherapy ProtocolsAmbulatory CaremedicineHumansPharmacology (medical)Prospective StudiesAgedPharmacologyChemotherapybusiness.industryLiver NeoplasmsMiddle Agedmedicine.diseasedigestive system diseasesSurgerySurvival RateIrinotecanOncologyFluorouracilCamptothecinFemaleFluorouracilFirst line chemotherapyColorectal Neoplasmsbusinessmedicine.drugAnti-Cancer Drugs
researchProduct

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.

2014

More effective treatments have become available for haematological malignancies from the early 2000s, but few large-scale population-based studies have investigated their effect on survival. Using EUROCARE data, and HAEMACARE morphological groupings, we aimed to estimate time trends in population-based survival for 11 lymphoid and myeloid malignancies in 20 European countries, by region and age.In this retrospective observational study, we included patients (aged 15 years and older) diagnosed with haematological malignancies, diagnosed up to Dec 31, 2007, and followed up to Dec 31, 2008. We used data from the 30 cancer registries (across 20 countries) that provided continuous incidence and …

AdultMalePathologymedicine.medical_specialtyAdolescentPopulationRisk AssessmentSeverity of Illness IndexDisease-Free SurvivalNOCohort StudiesYoung AdultCause of DeathConfidence IntervalsHematologic Neoplasms/diagnosis/mortality/therapyMedicineHumansRegistrieseducationSurvival analysisddc:613Cause of deathAgedRetrospective Studieseducation.field_of_studyRelative survivalbusiness.industryIncidence (epidemiology)Absolute risk reductionRetrospective cohort studyMiddle AgedCombined Modality TherapySurvival AnalysisEuropeOncologyHematologic NeoplasmsFemalebusinessDemographyCohort studyThe Lancet. Oncology
researchProduct

Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis.

2009

Aims: Essential thrombocythaemia (ET) and primary myelofibrosis (PMF) share some clinical and pathological features, but show different biological behaviour and prognosis. The latest contributions to understanding the nature of these disorders have focused on bone marrow microenvironment remodelling and proliferative stress, recognising megakaryocytes (MKCs) as “key-cells”. The aim of this study was to investigate the apoptotic profile of ET and PMF MKCs in order to further characterise the biology of these disorders. Methods: Bone marrow biopsy samples from 30 patients with ET, and 30 patients with PMF, were immunophenotypically studied for the expression of pro-apoptotic (Fas, Fas-L, Bax,…

AdultMalePathologymedicine.medical_specialtyBiopsyIDIOPATHIC MYELOFIBROSISApoptosisPOLYCYTHEMIA-VERASettore MED/08 - Anatomia PatologicaBiologyPathology and Forensic MedicineImmunophenotypingImmunophenotypingMegakaryocyteBone MarrowmedicineIn Situ Nick-End LabelingHumansTelomerase reverse transcriptaseMyelofibrosisMOLECULAR PERSPECTIVEAgedAged 80 and overTUNEL assayEssential thrombocythemiaC-MPLMUTATION STATUSGeneral MedicineMiddle Agedmedicine.diseasePrognosismedicine.anatomical_structureCHRONIC MYELOPROLIFERATIVE DISORDERSCELL-DEATHApoptosisPrimary MyelofibrosisRISK-FACTORSCancer researchBONE-MARROW ANGIOGENESISMYELOID METAPLASIAFemaleBone marrowMegakaryocytesThrombocythemia EssentialJournal of clinical pathology
researchProduct

Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

2002

Anderson-Fabry disease is a rare, X-chromosomal lipid storage disorder caused by a deficiency of lysosomal alpha-galactosidase A. Clinical manifestations of Anderson-Fabry disease include excruciating pain in the extremities (acroparaesthesia), skin vessel ectasia (angiokeratoma), corneal and lenticular opacity, cardiovascular disease, stroke and renal failure, only renal failure being a frequent cause of death. Heterozygote female carriers have often been reported as being asymptomatic or having an attenuated form of the disease. To evaluate the spectrum of clinical signs in heterozygotes, a comprehensive clinical examination was performed on 20 carriers of Anderson-Fabry disease. This rev…

AdultMalePathologymedicine.medical_specialtyHeterozygoteX ChromosomeLipid storage disorderAdolescentHeart DiseasesGastrointestinal DiseasesPhysical examinationDiseaseAsymptomaticGlycosphingolipidsGeneticsmedicineHumansParesthesiaChildGenetics (clinical)Cause of deathmedicine.diagnostic_testVascular diseasebusiness.industrymedicine.diseaseFabry diseaseDermatologyAngiokeratomaCerebrovascular DisordersChild PreschoolBlood VesselsFabry DiseaseFemaleKidney Diseasesmedicine.symptombusinessJournal of inherited metabolic disease
researchProduct

Strategy for Long-Term Surveillance at the German Childhood Cancer Registry - an Update

2011

Background The objective of this paper is to provide information about the quality (e.g. completeness, response) of long-term surveillance in German paediatric oncology and haematology based on the structures implemented by the German Childhood Cancer Registry (GCCR). Methods The GCCR contacts parents or patients to collect and update information on a minimal set of follow-up health status data (e.g. late relapses, subsequent neoplasms, current address) and exchanges this information regularly with the appropriate clinical trials. Results Between 2006 and 2010, GCCR approached a total of about 20,000 patients (contact at the age of 16 years, inquiry concerning the health status) in the cont…

AdultMalePediatricsmedicine.medical_specialtyAdolescentDatabases FactualLymphomaCross-sectional studyHealth StatusMEDLINECentral Nervous System NeoplasmsCohort StudiesGermanYoung AdultCause of DeathGermanyNeoplasmsHumansMedicineRegistriesSurvivorsYoung adultChildClinical Trials as TopicChildhood Cancer RegistryLeukemiabusiness.industryMiddle AgedLong-Term CareSurvival Analysislanguage.human_languageClinical trialLong-term careCross-Sectional StudiesChild PreschoolPopulation SurveillanceFamily medicinePediatrics Perinatology and Child HealthQuality of LifelanguageFemalebusinessCohort studyKlinische Pädiatrie
researchProduct

Mortality in patients with coeliac disease and their relatives: a cohort study.

2001

Summary Background Although previous studies have shown increased mortality in patients with coeliac disease and their relatives, no data are available in relation to different patterns of clinical presentation. We assessed mortality in patients with coeliac disease and their first-degree relatives. Methods We enrolled, in a prospective cohort study, 1072 adult patients with coeliac disease consecutively diagnosed in 11 gastroenterology units between 1962 and 1994, and their 3384 first-degree relatives. We compared the number of deaths up to 1998 with expected deaths and expressed the comparison as standardised mortality ratio (SMR) and relative survival ratio. Findings 53 coeliac patients …

AdultMalePediatricsmedicine.medical_specialtyMalabsorptionTime FactorsGlutensDiet therapyCoeliac diseaseCohort StudiesmedicineDiet Protein-RestrictedHumansProspective StudiesProspective cohort studyCause of deathRelative survivalbusiness.industryLymphoma Non-Hodgkincoeliac diaseaserelative survivalGeneral MedicineMiddle Agedmedicine.diseasePrognosismortalitySurgeryrelativeSurvival RateCeliac DiseaseStandardized mortality ratioPatient ComplianceFemalepatientbusinessCohort studyLancet (London, England)
researchProduct

Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study.

2001

Objective: To determine incidence of and risk factors for sudden unexpected death in epilepsy (SUDEP). Methods: Three epilepsy centers enrolled 4,578 patients and prospectively followed these patients for 16,463 patient-years. The cohort was screened for death annually. Deaths were investigated to determine whether SUDEP occurred. Potential risk factors were compared in SUDEP cases and in controls enrolled contemporaneously at the same center. Results: Incidence of SUDEP was 1.21/1,000 patient-years and was higher among women (1.45/1,000) than men (0.98/1,000). SUDEP accounted for 18% of all deaths. Occurrence of tonic-clonic seizures, treatment with more than two anticonvulsant medications…

AdultMalePediatricsmedicine.medical_specialtyTime FactorsAdolescentSudden deathCohort StudiesEpilepsyDeath SuddenRisk FactorsCause of DeathEpidemiologymedicineHumansProspective StudiesRisk factorProspective cohort studyChildCause of deathAgedAged 80 and overEpilepsybusiness.industryIncidenceInfant NewbornInfantepilepsy death sudepMiddle Agedmedicine.diseaseSurgeryChild PreschoolCohortSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessEpidemiologic MethodsCohort studyNeurology
researchProduct